Aas A M, Bergstad I, Thorsby P M, Johannesen O, Solberg M, Birkeland K I
Department of Nutrition and Dietetics, Aker University Hospital, Oslo, Norway.
Diabet Med. 2005 Mar;22(3):316-22. doi: 10.1111/j.1464-5491.2005.01421.x.
The aims of this study were to assess whether, in Type 2 diabetic patients with inadequate glycaemic control on oral hypoglycaemic agents (OHA), a lifestyle intervention programme based on exercise and diet counselling (i) was as effective as insulin treatment in controlling blood glucose, and (ii) could prevent the weight gain usually accompanying the introduction of insulin treatment.
Thirty-eight Type 2 diabetic subjects treated with OHA, HbA(1c) 8-10.5% and body mass index (BMI) 26-40 kg/m2, were randomized to the following treatments: (i) lifestyle intervention (L), (ii) lifestyle intervention + insulin treatment (L+I) and (iii) insulin treatment alone (I).
There was a reduction in HbA(1c) of -1.2 (interquartile range 1.0), -1.0 (1.7) and -1.5 (2.5)% in group L, L+I and I, respectively, and all treatment groups achieved beneficial changes in blood lipid variables. There was no significant difference between the groups in the change observed in levels of HbA(1c) between start and 12 months of treatment (P = 0.74). There was a significant difference in weight changes between groups (P < 0.01): group L reduced weight by median -3.0 (4.0) kg, groups L+I and I increased weight by 3.5 (3.4) and 4.9 (6.9) kg, respectively.
Lifestyle intervention was as effective as insulin treatment in improving glycaemic control in poorly controlled subjects with Type 2 diabetes, and resulted in weight loss during the intervention year. However, glycaemic control deteriorated and body weight increased in the lifestyle intervention group 1 year after the intervention stopped.
本研究旨在评估,对于口服降糖药(OHA)治疗后血糖控制不佳的2型糖尿病患者,基于运动和饮食咨询的生活方式干预计划(i)在控制血糖方面是否与胰岛素治疗同样有效,以及(ii)是否可以预防通常伴随胰岛素治疗出现的体重增加。
38名接受OHA治疗、糖化血红蛋白(HbA1c)为8 - 10.5%且体重指数(BMI)为26 - 40kg/m²的2型糖尿病受试者被随机分配至以下治疗组:(i)生活方式干预(L)组,(ii)生活方式干预 + 胰岛素治疗(L + I)组,以及(iii)单纯胰岛素治疗(I)组。
L组、L + I组和I组的HbA1c分别降低了-1.2(四分位间距1.0)、-1.0(1.7)和-1.5(2.5)%,并且所有治疗组的血脂变量均有有益变化。治疗开始至12个月期间,各组HbA1c水平变化无显著差异(P = 0.74)。各组体重变化存在显著差异(P < 0.01):L组体重中位数下降-3.0(4.0)kg,L + I组和I组体重分别增加3.5(3.4)和4.9(6.9)kg。
生活方式干预在改善血糖控制不佳的2型糖尿病患者的血糖方面与胰岛素治疗同样有效,并且在干预期间导致体重减轻。然而,干预停止1年后,生活方式干预组的血糖控制恶化且体重增加。